Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Vinod Mattoo; David Eckland; Mario Widel; Santiago Duran; Carmen Fajardo; Jorma Strand; Debbie Knight; Loren Grossman; David Oakley; Meng Tan

doi:10.1016/j.clinthera.2005.05.005

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.05.005 ◽

2005 ◽

Vol 27 (5) ◽

pp. 554-567 ◽

Cited By ~ 70

Author(s):

Vinod Mattoo ◽

David Eckland ◽

Mario Widel ◽

Santiago Duran ◽

Carmen Fajardo ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Metabolic Effects ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.10.012 ◽

2005 ◽

Vol 27 (10) ◽

pp. 1548-1561 ◽

Cited By ~ 48

Author(s):

Clifford J. Bailey ◽

Alfredas Bagdonas ◽

Josip Rubes ◽

Stephen O. McMorn ◽

Jill Donaldson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group ◽

Dose Combination

Download Full-text

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.05.021 ◽

2008 ◽

Vol 30 (6) ◽

pp. 1081-1088 ◽

Cited By ~ 19

Author(s):

S SCHWARTZ ◽

M RENDELL ◽

A AHMANN ◽

A THOMAS ◽

C ARAUZPACHECO ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Metabolic Effects ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.09.010 ◽

2006 ◽

Vol 28 (9) ◽

pp. 1318-1326 ◽

Cited By ~ 4

Author(s):

Sheng-Hwu Hsieh ◽

Jen-Der Lin ◽

Hung-Yu Cheng ◽

Cheng Ho ◽

Miaw-Jene Liou

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Study ◽

Immediate Release ◽

Chinese Patients ◽

Double Blind ◽

Parallel Group ◽

Group 12

Download Full-text

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12555 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1198-1201 ◽

Cited By ~ 5

Author(s):

K. Kaku ◽

M. Katou ◽

M. Igeta ◽

T. Ohira ◽

H. Sano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

Download Full-text

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial

Clinical Therapeutics ◽

10.1016/s0149-2918(04)90068-9 ◽

2004 ◽

Vol 26 (5) ◽

pp. 680-693 ◽

Cited By ~ 42

Author(s):

Meng Tan ◽

Don Johns ◽

Guillermo González Gálvez ◽

Oscar Antúnez ◽

Guadalupe Fabián ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Sensitivity ◽

Glycemic Control ◽

Double Blind ◽

Parallel Group ◽

Parallel Group Trial ◽

Group Trial

Download Full-text

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial

Diabetes Therapy ◽

10.1007/s13300-014-0072-0 ◽

2014 ◽

Vol 5 (1) ◽

pp. 267-283 ◽

Cited By ~ 45

Author(s):

Krzysztof Strojek ◽

Kun-Ho Yoon ◽

Veronika Hruba ◽

Jennifer Sugg ◽

Anna Maria Langkilde ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Weight Loss ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Controlled Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80201-1 ◽

2003 ◽

Vol 25 (7) ◽

pp. 2006-2021 ◽

Cited By ~ 17

Author(s):

Giuseppe Derosa ◽

Arrigo F.G. Cicero ◽

Leonardina Ciccarelli ◽

Roberto Fogari

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Group Comparison ◽

Double Blind ◽

Hypertensive Patients ◽

Parallel Group

Download Full-text

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13079 ◽

2017 ◽

Vol 20 (2) ◽

pp. 453-457 ◽

Cited By ~ 15

Author(s):

Takashi Kadowaki ◽

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Kenichi Nishimura ◽

Genki Kaneko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

Diabetic Medicine ◽

10.1111/j.1464-5491.2004.01426.x ◽

2005 ◽

Vol 22 (4) ◽

pp. 399-405 ◽

Cited By ~ 103

Author(s):

B. H. Charbonnel ◽

D. R. Matthews ◽

G. Schernthaner ◽

M. Hanefeld ◽

P. Brunetti ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Group Comparison ◽

Double Blind ◽

Parallel Group ◽

Comparison Trial

Download Full-text

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study

Diabetes Therapy ◽

10.1007/s13300-019-0604-8 ◽

2019 ◽

Vol 10 (3) ◽

pp. 951-963 ◽

Cited By ~ 7

Author(s):

Yasuo Terauchi ◽

Kazunori Utsunomiya ◽

Atsutaka Yasui ◽

Tetsuo Seki ◽

Gang Cheng ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Receptor Agonist ◽

Japanese Patients ◽

Double Blind ◽

Safety And Efficacy ◽

Parallel Group

Download Full-text